FDA warning letter consistency audit begun by HHS Inspector General.
This article was originally published in The Gray Sheet
Executive Summary
FDA WARNING LETTER CONSISTENCY AUDIT BEGUN BY HHS INSPECTOR GENERAL, agency staffers say. The HHS Office of the Inspector General is examining several FDA district offices for consistency in when they issue warning letters. The investigation covers all types of warning letters issued to all industries regulated by FDA.